This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jung, M. Articles by Dritschilo, A. Search for Related Content PubMed PubMed Citation Articles by Jung, M. Articles by Dritschilo, A.

Mutations in the p53 Gene in Radiation-sensitive and -resistant Human Squamous Carcinoma Cells¹

Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC 20007

Five of six human squamous cell carcinoma (SCC) cell lines characterized as radiation sensitive (SQ-38, SCC-9, SQ-9G) or radiation resistant (SQ-20B, SCC-35, JSQ-3) exhibited alterations of the p53 gene. The point mutations and a deletion were detected by using single-stranded conformational polymorphism analysis and polymerase chain reaction-direct sequencing. Interestingly, three of three radiation-sensitive and two of three radiation-resistant cell lines revealed mutations in the p53 gene. Point mutations were located in exons 4, 6, and 8 (at codons 72 and 298 in JSQ-3; 273 in SCC-35; 196 in SQ-38), and deletions consisted of 32 base pairs between codons 274 and 285 in SCC-9 and 1 base pair at codon 271 in SQ-9G. Three mutations resulted in substitutions for an arginine residue. Immunocytochemical analysis confirmed p53 protein overexpression in SCC-35 cells which contained a missense mutation at codon 273. In contrast to previous studies which linked alterations in ras, myc, and raf expression with radiation resistance, this study indicates that mutations in the tumor suppressor gene, p53, do not directly correlate with such resistance.

¹ This research was supported by Grants P01CA52066 and R01 CA45408 from the National Cancer Institute.

² To whom requests for reprints should be addressed.

Received 8/17/92. Accepted 10/ 1/92.

This article has been cited by other articles:

				M. M. Shareef, B. Brown, S. Shajahan, S. Sathishkumar, S. M. Arnold, M. Mohiuddin, M. M. Ahmed, and P. M. Spring Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-{kappa}B and NF-Y Activation in Oral Carcinoma Cells Mol. Cancer Res., January 1, 2008; 6(1): 89 - 98. [Abstract] [Full Text] [PDF]

				S. L. Scott, J. D. Earle, and P. H. Gumerlock Functional p53 Increases Prostate Cancer Cell Survival After Exposure to Fractionated Doses of Ionizing Radiation Cancer Res., November 1, 2003; 63(21): 7190 - 7196. [Abstract] [Full Text] [PDF]

				S. Dey, P. M. Spring, S. Arnold, J. Valentino, D. Chendil, W. F. Regine, M. Mohiuddin, and M. M. Ahmed Low-Dose Fractionated Radiation Potentiates the Effects of Paclitaxel in Wild-type and Mutant p53 Head and Neck Tumor Cell Lines Clin. Cancer Res., April 1, 2003; 9(4): 1557 - 1565. [Abstract] [Full Text] [PDF]

				I. M. Hussaini, J. E. Carpenter, G. T. Redpath, J. J. Sando, M. E. Shaffrey, and S. R. VandenBerg Protein kinase C-{eta} regulates resistance to UV- and {gamma}-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation Neuro-oncol, January 1, 2002; 4(1): 9 - 21. [Abstract] [PDF]

				S. J. Chmura, M. E. Dolan, A. Cha, H. J. Mauceri, D. W. Kufe, and R. R. Weichselbaum In Vitro and in Vivo Activity of Protein Kinase C Inhibitor Chelerythrine Chloride Induces Tumor Cell Toxicity and Growth Delay in Vivo Clin. Cancer Res., February 1, 2000; 6(2): 737 - 742. [Abstract] [Full Text]

				J. Fan and J. R. Bertino Modulation of Cisplatinum Cytotoxicity by p53: Effect of p53-Mediated Apoptosis and DNA Repair Mol. Pharmacol., November 1, 1999; 56(5): 966 - 972. [Abstract] [Full Text]

				W. K. Dahlberg, E. I. Azzam, Y. Yu, and J. B. Little Response of Human Tumor Cells of Varying Radiosensitivity and Radiocurability to Fractionated Irradiation Cancer Res., October 1, 1999; 59(20): 5365 - 5369. [Abstract] [Full Text] [PDF]

				J. M. Brown and B. G. Wouters Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents Cancer Res., April 1, 1999; 59(7): 1391 - 1399. [Abstract] [Full Text] [PDF]

				N. Nasrin, L. A. Mimish, P. S. Manogaran, M. Kunhi, D. Sigut, S. Al-Sedairy, and M. A. Hannan Cellular Radiosensitivity, Radioresistant DNA Synthesis, and Defect in Radioinduction of p53 in Fibroblasts From Atherosclerosis Patients Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 947 - 953. [Abstract] [Full Text]

				E. H. Chang, Y.-J. Jang, Z. Hao, G. Murphy, A. Rait, W. E. Fee Jr, H. H. Sussman, P. Ryan, Y. Chiang, and K. F. Pirollo Restoration of the G1 Checkpoint and the Apoptotic Pathway Mediated by Wild-type p53 Sensitizes Squamous Cell Carcinoma of the Head and Neck to Radiotherapy Arch Otolaryngol Head Neck Surg, May 1, 1997; 123(5): 507 - 512. [Abstract] [PDF]

				M. Ropke, J. Hald, P. Guldberg, J. Zeuthen, L. Norgaard, L. Fugger, A. Svejgaard, S. V. D. Burg, H. W. Nijman, C. J. M. Melief, et al. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide PNAS, December 10, 1996; 93(25): 14704 - 14707. [Abstract] [Full Text] [PDF]

				A Di Leonardo, S P Linke, K Clarkin, and G M Wahl DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., November 1, 1994; 8(21): 2540 - 2551. [Abstract] [PDF]